Azelastine Eyedrops |
Optivar |
Article: Azelastine
![]() | |
| Azelastine | |
| Systematic (IUPAC) name | |
| 4-[(4-chlorophenyl)methyl]-2- (1-methylazepan-4-yl)-phthalazin-1-one | |
| Identifiers | |
| CAS number | 58581-89-8 |
| ATC code | R01AC03 R06AX19, S01GX07 |
| PubChem | 2267 |
| DrugBank | APRD00813 |
| Chemical data | |
| Formula | C22H24ClN3O |
| Mol. weight | 381.898 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Azelastine is an antihistamine and mast cell stabilizer available as a nasal spray (AstelinĀ®) for hay fever and as eye drops (OptilarĀ®) for allergic conjunctivitis.
Resources
- Azelastine Eyedrops (Drug Digest)
- Optivar (Drug Digest)

Not Signed In - 

